Comparative Effectiveness Research (CER): Career Opportunities for Pharmacology Graduates
Comparative Effectiveness Research (CER) has been much in the news lately. The American Recovery and Reinvestment Act of 2009 (ARRA) has set aside over $1 billion for the “development and dissemination” of research comparing the effectiveness and outcomes of different health care treatments and strategies (Iglehart, 2009). As part of this effort, the Institute of Medicine was commissioned to recommend national priorities for CER. Their report in June (IOM, 2009) presents a definition of CER, along with a list of 100 priority questions relating to health care delivery that should be addressed quickly, and an outline strategy to facilitate an ongoing and robust CER enterprise. Should pharmacologists be following these developments?